Inventiva (IVA) Cash from Operations (2019 - 2025)
Inventiva's (IVA) quarterly Cash from Operations came in at 121629068.47 in Q2 2025, up 333.64% year-on-year from 28048563.88 in Q2 2024, and up 333.64% quarter-over-quarter from 52058899.21 in Q2 2024.
Inventiva (IVA) Cash from Operations (2019 - 2025) Analysis & Trends
Inventiva's Cash from Operations history runs 6 years deep, the most recent figure standing at 121629068.47 for Q2 2025.
- On a quarterly basis, Cash from Operations rose 333.64% year-over-year to 121629068.47 in Q2 2025; TTM through Jun 2025 was 15458233.26, a 112.0% increase from a year earlier, with the FY2025 full-year figure at 122089540.0, down 32.96% from the prior year.
- Cash from Operations improved to 121629068.47 in Q2 2025 per IVA's latest filing, from 52058899.21 in the prior quarter.
- Across five years, Cash from Operations topped out at 121629068.47 in Q2 2025 and bottomed at 52058899.21 in Q2 2024.
- The 4-year median for Cash from Operations is 22641473.06 (2021), against an average of 4433352.46.
- Across the five-year window, Cash from Operations plunged 265.59% in 2021 and soared 333.64% in 2025, its largest moves.
- Year by year, Cash from Operations stood at 22641473.06 in 2021, then fell by 18.15% to 26751906.17 in 2022, then slumped by 94.6% to 52058899.21 in 2024, then jumped by 333.64% to 121629068.47 in 2025.
- Per Business Quant, the three latest IVA Cash from Operations figures stand at 121629068.47 (Q2 2025), 52058899.21 (Q2 2024), and 26751906.17 (Q4 2022).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -19.59 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 201.34 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.53 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.43 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 1.08 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -354.17 Mn |
| 10 | Inventiva | 842.48 Mn | 842.48 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 121.63 Mn |
| Jun 30, 2025 | 121.63 Mn |
| Jun 30, 2024 | -52.06 Mn |
| Jun 30, 2024 | -52.06 Mn |
| Dec 31, 2022 | -26.75 Mn |
| Dec 31, 2022 | -26.75 Mn |
| Sep 22, 2022 | -27.36 Mn |
| Sep 22, 2022 | -27.36 Mn |
| Dec 31, 2021 | -22.64 Mn |
| Dec 31, 2021 | -22.64 Mn |
| Jun 30, 2021 | -14.46 Mn |
| Jun 30, 2021 | -14.46 Mn |
| Mar 31, 2021 | -9.39 Mn |
| Mar 31, 2021 | -9.39 Mn |
| Dec 31, 2020 | -8.55 Mn |
| Dec 31, 2020 | -8.55 Mn |
| Jun 30, 2020 | -3.96 Mn |
| Jun 30, 2020 | -3.96 Mn |
| Mar 31, 2020 | -3.95 Mn |
| Mar 31, 2020 | -3.95 Mn |